CHIO3: CHemotherapy combined with immune checkpoint inhibitor for operable stage IIIA/B (N2) Non-Small cell lung cancer (AFT-46).
      Google Scholar   
Citation:
Lung Cancer vol 215 109374
Year:
2026
Type:
Manuscript
Funding:
AFT
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
Yes
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
3316   4350  
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
AstraZeneca  
Grants:
P30CA044579  
Corr. Author:
 
Authors:
                         
Networks:
BAPTIST, CA249, LAPS-IL057, LAPS-MA036, LAPS-NC010, LAPS-TX035, NY141   
Study
AFT-46
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: